Vivos Therapeutics, Inc. (VVOS)

USD 4.54

(-7.35%)

Market Cap (In USD)

21.95 Million

Revenue (In USD)

13.8 Million

Net Income (In USD)

-13.58 Million

Avg. Volume

1.32 Million

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1.91-13.4
PE
-
EPS
-
Beta Value
7.678
ISIN
US92859E2072
CUSIP
92859E108
CIK
1716166
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. R. Kirk Huntsman
Employee Count
-
Website
https://vivos.com
Ipo Date
2020-12-11
Details
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. Vivos Therapeutics also offers VivoScore Program, a screening and home sleep test in adults and children. The company markets and sells its Vivos System to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Highlands Ranch, Colorado.